LascoƱa, Kyver Clayton A.
HRN: 22-24-02 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/29/2023
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
07/29/2023
08/02/2023
PO
2.5ml Then 1ml
OD
PCAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes